Vanda Pharmaceuticals to Participate in B. Riley Securities 2026 Mind, Muscle & Vision Summit
核心洞察
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston, Massachusetts.
The event is scheduled for Thursday, July 16, 2026, as announced by the company on July 10, 2026.
Vanda is a global biopharmaceutical company focused on developing and commercializing innovative therapies to address high unmet medical needs.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) has announced its participation in the upcoming B. Riley Securities 2026 Mind, Muscle & Vision Summit. The Washington-based biopharmaceutical company will engage in a fireside chat at the event, which is set to take place in Boston, Massachusetts on Thursday, July 16, 2026.
The announcement was made via press release on July 10, 2026, signaling the company's continued engagement with the investment and healthcare communities.
Vanda Pharmaceuticals describes itself as a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. The company trades on the Nasdaq under the ticker symbol VNDA.
Further details regarding the specific topics to be discussed during the fireside chat or the executives representing Vanda at the summit were not disclosed in the announcement. The B. Riley Securities Mind, Muscle & Vision Summit convenes investors and companies operating across neuroscience, musculoskeletal, and ophthalmology therapeutic areas.
Corporate inquiries can be directed to Kevin Moran, Senior Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals Inc.